Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease

NICE guidelines [CG181] Published date:

This clinical guideline (published July 2014) updates and replaces NICE clinical guideline 67 (published May 2008) and NICE technology appraisal guidance 94 (published January 2006). It offers evidence-based advice on the care and treatment of people at risk of cardiovascular disease and people who have had previous cardiovascular disease. It includes new and updated recommendations on risk assessment, lifestyle modifications and the use of lipid-lowering drugs.

Get involved